文献速递脑血管病

全身性炎症对非糖尿病缺血性卒中患者胰岛素抵抗与预后的中介作用

Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke.
PubMed 文献 · Stroke · 2023-02-01

研究纳入CNSR-III中3808例非糖尿病缺血性卒中患者,随访1年,采用HOMA-IR评估胰岛素抵抗,基线测量hs-CRP与Lp-PLA2活性。校正混杂因素后,较高HOMA-IR四分位与卒中复发、缺血性卒中及复合血管事件风险升高相关,尤其在LAA亚型;hs-CRP部分中介该关联,中介比例卒中复发5.9%、复合血管事件7.5%,Lp-PLA2活性未见中介效应。

要点

  • 非糖尿病缺血性卒中患者中,较高HOMA-IR与卒中复发及复合血管事件风险升高相关。
  • hs-CRP部分中介HOMA-IR与卒中复发(5.9%)及复合血管事件(7.5%)的关联。
  • Lp-PLA2活性未观察到中介胰岛素抵抗与卒中结局关联的证据。

核心结论

  • 非糖尿病缺血性卒中患者中,胰岛素抵抗与不良临床结局相关,该关联部分由hs-CRP以较小幅度中介。

研究设计与样本

  • 基于CNSR-III(第三次中国国家卒中登记)的非糖尿病缺血性卒中患者,卒中发病后随访1年。
  • 胰岛素抵抗采用稳态模型评估法(HOMA-IR)判定,基线测量hs-CRP和Lp-PLA2活性。
  • 主要结局为卒中复发,其他结局包括复合血管事件、死亡和不良功能结局(改良Rankin量表评分3-6分)。
  • 采用多变量Cox或logistic回归分析HOMA-IR与研究结局的关联,并行中介分析检验全身性炎症的中介关系。

主要发现

  • 共纳入3808例非糖尿病缺血性卒中患者,HOMA-IR中位数为1.79(四分位距1.05-2.97)。
  • 校正潜在混杂因素后,较高HOMA-IR四分位与卒中复发、缺血性卒中和复合血管事件风险升高相关,尤其在LAA亚型中。
  • hs-CRP部分中介HOMA-IR指数与缺血性卒中预后的关联,中介比例卒中复发5.9%、复合血管事件7.5%。
  • 未观察到Lp-PLA2活性中介胰岛素抵抗与卒中结局关联的证据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Insulin resistance is associated with stroke recurrence and poor functional outcomes of nondiabetic patients with ischemic stroke. The study aimed to investigate whether the association between insulin resistance and the prognosis of nondiabetic patients with ischemic stroke was mediated by systematic inflammation. METHODS: Patients with ischemic stroke but without a history of diabetes who were enrolled in CNSR-III (Third China National Stroke Registry) were included in the study and followed up for 1 year after stroke onset. Insulin resistance was determined by using the homeostasis model assessment for insulin resistance (HOMA-IR) method. hs-CRP (high-sensitivity C-reactive protein) and Lp-PLA2 (lipoprotein-associated phospholipase A2) activity were measured at baseline. The primary outcome was stroke recurrence, and other outcomes included composite vascular events, mortality, and poor functional outcome (modified Rankin Scale score, 3-6). Multivariable Cox or logistic regression analyses were performed to estimate the association between HOMA-IR and the study outcomes. A mediation analysis was performed to examine the relationship between insulin resistance and the study outcomes mediated by systemic inflammation. RESULTS: Among a total of 3808 nondiabetic patients with ischemic stroke who were included in the study, the median HOMA-IR was 1.79 (interquartile range, 1.05-2.97). After adjustments for potential confounders, higher HOMA-IR quartiles were associated with higher risks of stroke recurrence, ischemic stroke, and composite vascular events, especially in the large artery atherosclerosis subtype. hs-CRP partially mediated the association between the HOMA-IR index and the prognosis of ischemic stroke (mediation proportion, 5.9% for stroke recurrence and 7.5% for composite vascular events). No evidence of Lp-PLA2 activity mediating the association of insulin resistance with stroke outcomes was observed. CONCLUSIONS: Our study found that insulin resistance was associated with poor clinical outcomes in nondiabetic patients with ischemic stroke, which was partially mediated by hs-CRP with a modest amount.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Jin A, Wang S, Li J, et al. Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke. Stroke. 2023. PMID: 36722344. doi:10.1161/STROKEAHA.122.039542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。